Tonix Pharmaceuticals stock halted ahead of FDA approval news
FRANKFURT - Deutsche Bank AG (ETR:DBKGn), acting as the Stabilisation Coordinator, has announced the potential stabilization measures for Robert Bosch (NSE:BOSH) Finance LLC’s securities, which could commence today. The stabilization is in accordance with the rules set by the Commission Delegated Regulation (EU) 2016/1052 under the Market Abuse Regulation (EU/596/2014) and the UK Financial Conduct Authority’s Stabilisation Binding Technical Standards.
The securities in question are part of an offering by Robert Bosch Finance LLC, with Robert Bosch GmbH serving as the guarantor. The aggregate nominal amount for the offering is yet to be confirmed. The offering includes EUR 18 million Fixed Rate Notes (FRNs) with maturities of 3, 6, and 9 years, and the issue/offer price is set around benchmark spreads, which are yet to be determined.
The stabilization period is expected to start today and could last until July 9, 2025. During this time, the Stabilisation Managers, including BNP PARIBAS, Commerzbank (ETR:CBKG), Deutsche Bank, LBBW, Mizuho (NYSE:MFG), and Santander (BME:SAN), may over-allot securities or conduct transactions to support the market price of the securities at a level higher than that which might otherwise prevail. However, there is no guarantee that stabilization will occur, and it may end at any time. Any stabilization action or over-allotment will comply with all applicable laws and rules.
The announcement clarifies that this information is solely for informational purposes and does not constitute an offer to underwrite, subscribe for, or acquire securities in any jurisdiction. The securities are targeted at professional investors and high net worth individuals in the United Kingdom (TADAWUL:4280), qualified investors within the European Economic Area (EEA), and similar parties in the UK as defined by the UK Prospectus Regulation.
This notice also underscores that the securities have not been registered under the United States Securities Act of 1933 and, therefore, may not be offered or sold within the United States absent registration or an exemption from registration. There will be no public offering of the securities in the United States.
The details provided in this article are based on a press release statement. The London Stock Exchange (LON:LSEG)’s news service RNS, approved by the Financial Conduct Authority, has distributed this information. Terms and conditions regarding the use and distribution of this information may apply.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.